TY - JOUR
T1 - Association of itch triggers with atopic dermatitis severity and course in adults
AU - Silverberg, Jonathan I
AU - Lei, Donald
AU - Yousaf, Muhammad
AU - Janmohamed, Sherief R.
AU - Vakharia, Paras P.
AU - Chopra, Rishi
AU - Chavda, Rajeev
AU - Gabriel, Sylvie
AU - Patel, Kevin R.
AU - Singam, Vivek
AU - Kantor, Robert
AU - Hsu, Derek Y.
AU - Cella, David
N1 - Funding Information:
Funding Sources: This publication was made possible with support from the Agency for Healthcare Research and Quality (grant number K12 HS023011 ), the Dermatology Foundation , and Galderma .
Publisher Copyright:
© 2020 American College of Allergy, Asthma & Immunology
PY - 2020/11
Y1 - 2020/11
N2 - Background: Atopic dermatitis (AD) is associated with heterogeneous triggers of itch, which may affect AD course and severity. Objective: To characterize the triggers of itch in adult AD. Methods: This was a prospective dermatology practice–based study using questionnaires and evaluation by a dermatologist (n = 587). Thirteen itch triggers were assessed using the patient-reported outcomes measurement information system Itch-Triggers. Results: Overall, 381 (64.9%) patients reported greater than or equal to 1 itch trigger in the past week and 212 (36.1%) reported greater than or equal to 3 itch triggers. The most commonly reported triggers were stress (35.4%), sweat (30.5%), weather change (24.7%), dry air (24.4%), and heat (24.0%). In multivariable Poisson regression models, the number of itch triggers was associated with more severe patient-reported global AD severity, Numeric Rating Scale worst itch, Patient-Oriented Eczema Measure, Scoring Atopic Dermatitis sleep, Numeric Rating Scale skin pain, Eczema Area and Severity Index, and objective Scoring Atopic Dermatitis. The seasonality of AD was associated with distinct itch triggers. In multivariable logistic regression models, the number of itch triggers was associated with less than or equal to 3 months of AD remission during the year, greater than or equal to 2 AD flares, and AD being worse during some seasons. Four patterns of itch triggers were identified using latent class analysis, each associated with different clinical characteristics. Conclusion: Itch triggers are common and affect the course of AD. Itch triggers are an important end point to assess in patients with AD.
AB - Background: Atopic dermatitis (AD) is associated with heterogeneous triggers of itch, which may affect AD course and severity. Objective: To characterize the triggers of itch in adult AD. Methods: This was a prospective dermatology practice–based study using questionnaires and evaluation by a dermatologist (n = 587). Thirteen itch triggers were assessed using the patient-reported outcomes measurement information system Itch-Triggers. Results: Overall, 381 (64.9%) patients reported greater than or equal to 1 itch trigger in the past week and 212 (36.1%) reported greater than or equal to 3 itch triggers. The most commonly reported triggers were stress (35.4%), sweat (30.5%), weather change (24.7%), dry air (24.4%), and heat (24.0%). In multivariable Poisson regression models, the number of itch triggers was associated with more severe patient-reported global AD severity, Numeric Rating Scale worst itch, Patient-Oriented Eczema Measure, Scoring Atopic Dermatitis sleep, Numeric Rating Scale skin pain, Eczema Area and Severity Index, and objective Scoring Atopic Dermatitis. The seasonality of AD was associated with distinct itch triggers. In multivariable logistic regression models, the number of itch triggers was associated with less than or equal to 3 months of AD remission during the year, greater than or equal to 2 AD flares, and AD being worse during some seasons. Four patterns of itch triggers were identified using latent class analysis, each associated with different clinical characteristics. Conclusion: Itch triggers are common and affect the course of AD. Itch triggers are an important end point to assess in patients with AD.
UR - http://www.scopus.com/inward/record.url?scp=85087769639&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087769639&partnerID=8YFLogxK
U2 - 10.1016/j.anai.2020.06.014
DO - 10.1016/j.anai.2020.06.014
M3 - Article
C2 - 32544530
AN - SCOPUS:85087769639
SN - 1081-1206
VL - 125
SP - 552-559.e2
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 5
ER -